Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuning Xu

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Free Radical Biology & Medicine|January 25, 2024
Reprimo (RPRM) mediates neuronal ferroptosis via CREB-Nrf2/SCD1 pathways in radiation-induced brain injuryWenyu Shi, Jin Wang, Zhaojun Li, et al.
International Journal of Clinical Oncology|February 26, 2015
First-line gemcitabine and oxaliplatin (GEMOX) plus sorafenib, followed by sorafenib as maintenance therapy, for patients with advanced hepatocellular carcinoma: a preliminary studyYing Liu, Han Yue, Shuning Xu, et al.
Frontiers in Immunology|November 17, 2025
Integrative multi-omics analysis of gastric cancer evolution from precancerous lesions to metastasis identifies a deep learning-based prognostic modelYulin Ren, Xiaoyan Zhang, Ke Li, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 11, 2025
Corrigendum to "Dual-energy CT radiomics for predicting neoadjuvant chemotherapy response in locally advanced gastric cancer: A dual-vendor validation study" [Eur. J. Surg. Oncol. 51 (2025) 110548]Jing Li, Xiaoxiao Lin, Hongkun Yin, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 2, 2025
Dual-energy CT radiomics for predicting neoadjuvant chemotherapy response in locally advanced gastric cancer: A dual-vendor validation studyJing Li, Xiaoxiao Lin, Hongkun Yin, et al.
Biomedical Reports|April 3, 2026
Peroxiredoxin 4 suppresses ferroptosis in esophageal squamous cell carcinoma by activating the phosphoinositide 3-kinase  signaling pathwayKe Li, Shuning Xu, Hongtao Liu, et al.
Frontiers in Endocrinology|November 3, 2025
The anti-inflammatory effects of dexamethasone implants in eyes with heavy silicone oil: a prospective study on vitrectomy for diabetic retinopathyXingguo Zhang, Junliang Dong, Haomin Lu, et al.
Frontiers in Immunology|July 17, 2024
Glycosylphosphatidylinositol anchor biosynthesis pathway-based biomarker identification with machine learning for prognosis and T cell exhaustion status prediction in breast cancerHaodong Wu, Zhixuan Wu, Hongfeng Li, et al.
Journal of Cancer|August 2, 2021
Continuing Cetuximab <i>vs</i> Bevacizumab plus chemotherapy after first progression in wild-type <i>KRAS</i>, <i>NRAS</i> and <i>BRAF V600E</i> metastatic colorectal cancer: a randomized phase II trialDanyang Li, Feng Wang, Shuning Xu, et al.
Journal of Gastrointestinal Oncology|January 18, 2021
Short and long-term outcomes after proximal gastrectomy with double tract reconstruction for Siewert type III adenocarcinoma of the esophagogastric junction: a propensity score matching study from a 10-year experience in a high-volume hospitalFei Ma, Dandan Guo, Bin Zhang, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Free Radical Biology & Medicine|January 25, 2024
Reprimo (RPRM) mediates neuronal ferroptosis via CREB-Nrf2/SCD1 pathways in radiation-induced brain injuryWenyu Shi, Jin Wang, Zhaojun Li, et al.
International Journal of Clinical Oncology|February 26, 2015
First-line gemcitabine and oxaliplatin (GEMOX) plus sorafenib, followed by sorafenib as maintenance therapy, for patients with advanced hepatocellular carcinoma: a preliminary studyYing Liu, Han Yue, Shuning Xu, et al.
Frontiers in Immunology|November 17, 2025
Integrative multi-omics analysis of gastric cancer evolution from precancerous lesions to metastasis identifies a deep learning-based prognostic modelYulin Ren, Xiaoyan Zhang, Ke Li, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 11, 2025
Corrigendum to "Dual-energy CT radiomics for predicting neoadjuvant chemotherapy response in locally advanced gastric cancer: A dual-vendor validation study" [Eur. J. Surg. Oncol. 51 (2025) 110548]Jing Li, Xiaoxiao Lin, Hongkun Yin, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 2, 2025
Dual-energy CT radiomics for predicting neoadjuvant chemotherapy response in locally advanced gastric cancer: A dual-vendor validation studyJing Li, Xiaoxiao Lin, Hongkun Yin, et al.
Biomedical Reports|April 3, 2026
Peroxiredoxin 4 suppresses ferroptosis in esophageal squamous cell carcinoma by activating the phosphoinositide 3-kinase  signaling pathwayKe Li, Shuning Xu, Hongtao Liu, et al.
Frontiers in Endocrinology|November 3, 2025
The anti-inflammatory effects of dexamethasone implants in eyes with heavy silicone oil: a prospective study on vitrectomy for diabetic retinopathyXingguo Zhang, Junliang Dong, Haomin Lu, et al.
Frontiers in Immunology|July 17, 2024
Glycosylphosphatidylinositol anchor biosynthesis pathway-based biomarker identification with machine learning for prognosis and T cell exhaustion status prediction in breast cancerHaodong Wu, Zhixuan Wu, Hongfeng Li, et al.
Journal of Cancer|August 2, 2021
Continuing Cetuximab <i>vs</i> Bevacizumab plus chemotherapy after first progression in wild-type <i>KRAS</i>, <i>NRAS</i> and <i>BRAF V600E</i> metastatic colorectal cancer: a randomized phase II trialDanyang Li, Feng Wang, Shuning Xu, et al.
Journal of Gastrointestinal Oncology|January 18, 2021
Short and long-term outcomes after proximal gastrectomy with double tract reconstruction for Siewert type III adenocarcinoma of the esophagogastric junction: a propensity score matching study from a 10-year experience in a high-volume hospitalFei Ma, Dandan Guo, Bin Zhang, et al.
Pageof 4